ADRB2 and neoplasm: We have demonstrated that systemic β-AR activation, using acute dynamic exercise as an experimental model, mobilizes TCR-γδ T-cells to the peripheral blood and, for the first time here, augments their ex vivo expansion and anti-tumor activity.